Literature DB >> 683618

Incidence of subclinical metastasis in stage I and II ovarian carcinoma.

M S Piver, J J Barlow, S B Lele.   

Abstract

The incidence of unsuspected metastasis to the diaphgram, retroperitoneal lymph nodes, and omentum as well as malignant cytologic peritoneal washings in women with presumed localized ovarian cancer is presented. Of the women with presumed Stage I ovarian cancer, from our clinical experience and those reported in the literature, 11.3% were found to have diaphragmatic metastases, 13.3% had aortic lymph node metastases, 8.1% had pelvic lymph node metastases, 3.2% had omental metastases, and 32.9% had malignant peritoneal washings. In Stage II ovarian cancer, 23% were found to have diaphgragmatic metastases, 10.0% had aortic lymph node metastases, 0% had omental metastases, and 12.5% had malignant peritoneal washings.

Entities:  

Mesh:

Year:  1978        PMID: 683618

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  14 in total

1.  Preclinical evaluation of Mab CC188 for ovarian cancer imaging.

Authors:  M Xu; M P Rettig; G Sudlow; B Wang; W J Akers; D Cao; D G Mutch; J F DiPersio; S Achilefu
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

2.  Fractionated Palliative Pelvic Radiotherapy as an Effective Modality in the Management of Recurrent/Refractory Epithelial Ovarian Cancers: An Institutional Experience.

Authors:  Anshuma Bansal; Bhavana Rai; Shikhar Kumar; Vanita Suri; Sushmita Ghoshal
Journal:  J Obstet Gynaecol India       Date:  2016-07-29

3.  S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.

Authors:  U Wagner; P Harter; F Hilpert; S Mahner; A Reuß; A du Bois; E Petru; W Meier; P Ortner; K König; K Lindel; D Grab; P Piso; O Ortmann; I Runnebaum; J Pfisterer; D Lüftner; N Frickhofen; F Grünwald; B O Maier; J Diebold; S Hauptmann; F Kommoss; G Emons; B Radeleff; M Gebhardt; N Arnold; G Calaminus; I Weisse; J Weis; J Sehouli; D Fink; A Burges; A Hasenburg; C Eggert
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

4.  [Surgical therapy of ovarian cancer].

Authors:  A Pfleiderer
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

5.  Does omentectomy prevent malignant small bowel obstruction?

Authors:  J L Weese; F D Ottery; S E Emoto
Journal:  Clin Exp Metastasis       Date:  1988 Jul-Aug       Impact factor: 5.150

Review 6.  Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-05       Impact factor: 1.798

7.  Results of ovary tumor treatment with abdominally administered (198)Au evaluated on the basis of long term follow up.

Authors:  Mihály Patyánik; Arpád Mayer; István Polgár
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

Review 8.  Ovarian cancer.

Authors:  Ursula A Matulonis; Anil K Sood; Lesley Fallowfield; Brooke E Howitt; Jalid Sehouli; Beth Y Karlan
Journal:  Nat Rev Dis Primers       Date:  2016-08-25       Impact factor: 52.329

9.  Fertility preservation in patients with early epithelial ovarian cancer.

Authors:  Yong-Soon Kwon; Ho-Suap Hahn; Tae-Jin Kim; In-Ho Lee; Kyung-Taek Lim; Ki-Heon Lee; Jae-Uk Shim; Jung-Eun Mok
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

10.  An audit of surgical treatment of ovarian cancer in a metropolitan health region. Association of Obstetricians and Gynaecologists of the North East Thames Region.

Authors:  C N Hudson; P Potsides; O M Curling
Journal:  J R Soc Med       Date:  1991-04       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.